Arch Therapeutics is a medical device company that is engaged in developing a novel approach for controlling bleeding and fluid loss during surgery and trauma care. The company’s aim is to develop and commercialize products, based on its innovative technology platform, that make surgery and interventional care faster and safer for patients. AC5, the company’s flagship development-stage product candidate, is being designed to elegantly achieve homeostasis in minimally invasive and open surgical procedures. For more information, visit the company’s Web site at www.archtherapeutics.com.